113 related articles for article (PubMed ID: 8824769)
21. Proliferating cell nuclear antigen associates to protein complexes containing cyclins/cyclin dependent kinases susceptible of inhibition by KRPs during maize germination.
Garza-Aguilar SM; Axosco-Marín J; Lara-Núñez A; Guerrero-Molina ED; Lemus-Enciso AT; García-Ramírez E; Vázquez-Ramos JM
Plant Sci; 2019 Mar; 280():297-304. PubMed ID: 30824007
[TBL] [Abstract][Full Text] [Related]
22. PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines.
Coltrera MD; Gown AM
J Histochem Cytochem; 1991 Jan; 39(1):23-30. PubMed ID: 1670579
[TBL] [Abstract][Full Text] [Related]
23. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
Li Y; Jenkins CW; Nichols MA; Xiong Y
Oncogene; 1994 Aug; 9(8):2261-8. PubMed ID: 7913544
[TBL] [Abstract][Full Text] [Related]
24. p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases.
Medema RH; Klompmaker R; Smits VA; Rijksen G
Oncogene; 1998 Jan; 16(4):431-41. PubMed ID: 9484832
[TBL] [Abstract][Full Text] [Related]
25. Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells.
Javier AF; Bata-Csorgo Z; Ellis CN; Kang S; Voorhees JJ; Cooper KD
J Clin Invest; 1997 May; 99(9):2094-9. PubMed ID: 9151781
[TBL] [Abstract][Full Text] [Related]
26. PCNA is recruited to irradiated chromatin in late S-phase and is most pronounced in G2 phase of the cell cycle.
Bártová E; Suchánková J; Legartová S; Malyšková B; Hornáček M; Skalníková M; Mašata M; Raška I; Kozubek S
Protoplasma; 2017 Sep; 254(5):2035-2043. PubMed ID: 28168519
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: a new view of the cell cycle.
Landberg G; Tan EM; Roos G
Exp Cell Res; 1990 Mar; 187(1):111-8. PubMed ID: 1967582
[TBL] [Abstract][Full Text] [Related]
28. Localization of cyclin A at the sites of cellular DNA replication.
Sobczak-Thepot J; Harper F; Florentin Y; Zindy F; Brechot C; Puvion E
Exp Cell Res; 1993 May; 206(1):43-8. PubMed ID: 8097727
[TBL] [Abstract][Full Text] [Related]
29. Dynamic changes in subnuclear NP95 location during the cell cycle and its spatial relationship with DNA replication foci.
Miura M; Watanabe H; Sasaki T; Tatsumi K; Muto M
Exp Cell Res; 2001 Feb; 263(2):202-8. PubMed ID: 11161719
[TBL] [Abstract][Full Text] [Related]
30. Requirement for proliferating cell nuclear antigen expression during stages of the Chinese hamster ovary cell cycle.
Liu YC; Marraccino RL; Keng PC; Bambara RA; Lord EM; Chou WG; Zain SB
Biochemistry; 1989 Apr; 28(7):2967-74. PubMed ID: 2568123
[TBL] [Abstract][Full Text] [Related]
31. p53-independent increase in p21WAF1 and reciprocal down-regulation of cyclin A and proliferating cell nuclear antigen in bromodeoxyuridine-mediated growth arrest of human melanoma cells.
Strasberg Rieber M; Welch DR; Miele ME; Rieber M
Cell Growth Differ; 1996 Feb; 7(2):197-202. PubMed ID: 8822203
[TBL] [Abstract][Full Text] [Related]
32. cAMP-mediated inhibition of DNA replication and S phase progression: involvement of Rb, p21Cip1, and PCNA.
Naderi S; Wang JY; Chen TT; Gutzkow KB; Blomhoff HK
Mol Biol Cell; 2005 Mar; 16(3):1527-42. PubMed ID: 15647383
[TBL] [Abstract][Full Text] [Related]
33. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining.
van Dierendonck JH; Wijsman JH; Keijzer R; van de Velde CJ; Cornelisse CJ
Am J Pathol; 1991 May; 138(5):1165-72. PubMed ID: 1673821
[TBL] [Abstract][Full Text] [Related]
34. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase.
Celis JE; Celis A
Proc Natl Acad Sci U S A; 1985 May; 82(10):3262-6. PubMed ID: 2860667
[TBL] [Abstract][Full Text] [Related]
35. Human DNA polymerase epsilon colocalizes with proliferating cell nuclear antigen and DNA replication late, but not early, in S phase.
Fuss J; Linn S
J Biol Chem; 2002 Mar; 277(10):8658-66. PubMed ID: 11741962
[TBL] [Abstract][Full Text] [Related]
36. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
[TBL] [Abstract][Full Text] [Related]
37. Cell cycle-dependent regulation of nuclear p53 traffic occurs in one subclass of human tumor cells and in untransformed cells.
David-Pfeuty T; Chakrani F; Ory K; Nouvian-Dooghe Y
Cell Growth Differ; 1996 Sep; 7(9):1211-25. PubMed ID: 8877102
[TBL] [Abstract][Full Text] [Related]
38. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.
Luo Y; Hurwitz J; Massagué J
Nature; 1995 May; 375(6527):159-61. PubMed ID: 7753174
[TBL] [Abstract][Full Text] [Related]
39. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
Bilodeau JF; Faure R; Piedboeuf B; Mirault ME
Exp Cell Res; 2000 May; 256(2):347-57. PubMed ID: 10772807
[TBL] [Abstract][Full Text] [Related]
40. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
